André-Jacques Auberton-Hervé

Soitec Solar GmbH engages in the development, manufacture, and marketing of photovoltaic power plants and components. The company was founded by Hansjörg Lerchenmüller and Andreas W. Bett in February 2005 and is headquartered in Frankfurt, Germany.

Altatech SAS manufactures of equipment for semiconductor, LEDs, MEMS and photovoltaic devices. Its products include NanoDeposition, NanoVision, NanoPrinting, and services. The firm develops a unique portfolio of technologies including standard and customized equipment and expertise in mature and advanced process deposition, and holistic defect inspection and metrology. The company was founded by Jean Luc Delcarri and Gilles du Sordet in 2004 and is headquartered in Montbonnot Saint Martin, France.

Association Nationale de la Recherche et de la Technologie is a French company that brings together project engineering experts and managers of European and international affairs. The non-profit company is based in Paris, France. The company shares their experiences of assembly and project monitoring, confront their understanding of developments in the Horizon 2020 research framework program, and invite political experts and decision-makers to deepen certain aspects of the European research program or policy.

Ganotec, Inc. provides multi-disciplinary construction and maintenance services. Its services include industrial services such as oil and gas and petrochemical, pulp and paper, power generation and pipe fabrication and value added services such as project management, estimating, direct hire construction, maintenance services and subcontract management. The company was founded in 1979 and is headquartered in Trois-Rivières, Canada.

Nanosciences Fondation supports the research focused on Nanosciences at the frontiers of nanoelectronics which is performed within associated network of laboratories. The company is headquartered in Grenoble, France.

Lyon Pôle Bourse engages in the provision of regional economy development services. The company was founded in 2009 and is headquartered in Lyon, France.

Part of Soitec SA, Soitec USA LLC is a private company that wholesales silicon on insulator wafers for the semiconductor industry. The company is based in Peabody, MA.

Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France.

Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The private company is based in Watertown, MA. The company was founded by Michael Prywata.

Chavant Capital Acquisition Corp. operates as a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination. It intend to focus in the advanced manufacturing and advanced materials technology sectors. The company was founded on March 19, 2021 is headquartered in New York, NY.

Transmutex SA is a Swiss company that engages in producing clean energy from nuclear waste. The company is based in Chene-Bougeries, Switzerland. It was founded by Federico Carminati and Franklin Servan-Schreiber. Franklin Servan-Schreiber has been the CEO of the company since 2019.

Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020.